Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group-Reference-Cited by-同舟云学术

Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group

Published:2022-10-29 Issue:1 Volume:37 Page:212-216
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Ohki Kentaro^ORCID,Butler Ellie R.,Kiyokawa Nobutaka,Hirabayashi Shinsuke,Bergmann Anke K.,Möricke Anja,Boer Judith M.^ORCID,Cavé Hélène^ORCID,Cazzaniga Giovanni,Yeoh Allen Eng Juh,Sanada Masashi^ORCID,Imamura Toshihiko,Inaba Hiroto^ORCID,Mullighan Charles G.^ORCID,Loh Mignon L.,Norén-Nyström Ulrika^ORCID,Shih Lee-Yung^ORCID,Zaliova Marketa^ORCID,Pui Ching-Hon^ORCID,Haas Oskar A.^ORCID,Harrison Christine J.,Moorman Anthony V.^ORCID,Manabe Atsushi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-022-01737-4.pdf

Reference11 articles.

1. Moorman AV, Antony G, Wade R, Butler ER, Enshaei A, Harrison CJ, et al. Time to cure for childhood and young adult acute lymphoblastic leukemia is independent of early risk factors: long-term follow-up of the UKALL2003 trial. J Clin Oncol. 2022;JCO2200245. https://doi.org/10.1200/JCO.22.00245. Online ahead of print.

2. Moorman AV, Schwab C, Winterman E, Hancock J, Castleton A, Cummins M, et al. Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion. Br J Haematol. 2020;191:844–51.

3. Suzuki K, Okuno Y, Kawashima N, Muramatsu H, Okuno T, Wang X, et al. MEF2D-BCL9 fusion gene is associated with high-risk acute B-cell precursor lymphoblastic leukemia in adolescents. J Clin Oncol. 2016;34:3451–9.

4. Liu YF, Wang BY, Zhang WN, Huang JY, Li BS, Zhang M, et al. Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia. EBioMedicine. 2016;8:173–83.

5. Yasuda T, Tsuzuki S, Kawazu M, Hayakawa F, Kojima S, Ueno T, et al. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults. Nat Genet. 2016;48:569–74.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic and clinical characteristics of acute B-cell lymphoblastic leukemia with MEF2D fusions and report of two novel MEF2D rearrangements;Annals of Hematology;2024-07-11

2. Genetic alterations in lymphoblastic leukaemia / lymphoma – a practical guide to WHO HAEM5;Medizinische Genetik;2024-03-04

3. Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia;Cancers;2024-02-21

4. Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL;Journal of Clinical Oncology;2023-12-20

5. Novel Biomarkers and Molecular Targets in ALL;Current Hematologic Malignancy Reports;2023-12-04